Dr. Andreas Reichl has over 25 years of pharmaceutical industry experience, featuring a diverse background comprising of a medical doctorate and key positions held across clinical operations, project management and medical science.  Andreas’ expertise lies in Clinical Pharmacology, where he has been advising many clients on time and cost effective study designs, streamlined project execution, and reporting.

At Quotient Sciences, Andreas holds a Senior Drug Development Consultant position.  Prior to his tenure at Quotient, Andreas gained extensive CRO experience at Fortrea, Labcorp Drug Development, Covance and Radiant Research, after having spent 2 years in Academia (at University of Florida).